Back
Swedish Orphan Biovitrum AB Vs. Hansa Biopharma AB Industry Stock Comparison
Buy
55
BIOVF
Swedish Orphan Biovitrum AB
Last Price:
28.62
Seasonality Move:
5.27%
Sell
39
HNSBF
Hansa Biopharma AB
Last Price:
2.83
Seasonality Move:
-0.32%
Buy
55
Swedish Orphan Biovitrum AB (BIOVF)
is a Buy
Is Swedish Orphan Biovitrum AB a Buy, Sell or Hold?
- The current Swedish Orphan Biovitrum AB [BIOVF] share price is $28.62. The Score for BIOVF is 55, which is 10% above its historic median score of 50, and infers lower risk than normal.
- BIOVF is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
39
Hansa Biopharma AB (HNSBF)
is a Sell
Is Hansa Biopharma AB a Buy, Sell or Hold?
- The current Hansa Biopharma AB [HNSBF] share price is $2.83. The Score for HNSBF is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
- HNSBF is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
BIOVF Stock Price Chart
What is Swedish Orphan Biovitrum AB's stock price today?
-
The Swedish Orphan Biovitrum AB share price today is $28.62
The current trend is relatively stagnant and BIOVF is experiencing slight buying pressure.
HNSBF Stock Price Chart
What is Hansa Biopharma AB's stock price today?
-
The Hansa Biopharma AB share price today is $2.83
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and HNSBF is experiencing slight buying pressure.
BIOVF Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.64 | Sell |
| Relative Strength Index (14 RSI): | 45.57 | Sell |
| Chaikin Money Flow: | 0 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (27.46 - 30.86) | Sell |
| Bollinger Bands (100): | (25.97 - 31.57) | Sell |
HNSBF Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.16 | Sell |
| Relative Strength Index (14 RSI): | 8.68 | Sell |
| Chaikin Money Flow: | 0 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (3.16 - 3.82) | Sell |
| Bollinger Bands (100): | (2.81 - 3.47) | Sell |
BIOVF Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 27.94 | Buy |
| 20-day SMA: | 28.61 | Buy |
| 50-day SMA: | 29.8 | Sell |
| 200-day SMA: | 27.22 | Buy |
| 8-day EMA: | 28.09 | Buy |
| 20-day EMA: | 28.6 | Buy |
| 50-day EMA: | 29.21 | Sell |
| 200-day EMA: | 27.47 | Buy |
HNSBF Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 3.14 | Sell |
| 20-day SMA: | 3.45 | Sell |
| 50-day SMA: | 3.35 | Sell |
| 200-day SMA: | 3.06 | Sell |
| 8-day EMA: | 3.06 | Sell |
| 20-day EMA: | 3.31 | Sell |
| 50-day EMA: | 3.33 | Sell |
| 200-day EMA: | 3.66 | Sell |
Swedish Orphan Biovitrum AB Earnings Growth & BIOVF Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Hansa Biopharma AB Earnings Growth & HNSBF Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Swedish Orphan Biovitrum AB Technical Analysis
| Nov 26 | Nov 27 | Nov 29 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 6 | Dec 9 | Dec 10 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | Dec | |||||||||
| 26 | 27 | 29 | 02 | 03 | 04 | 05 | 06 | 09 | 10 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Hansa Biopharma AB Technical Analysis
| Nov 26 | Nov 27 | Nov 29 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 6 | Dec 9 | Dec 10 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | Dec | |||||||||
| 26 | 27 | 29 | 02 | 03 | 04 | 05 | 06 | 09 | 10 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||